Upcoming Seminars and Workshops
CVI Seminar Series
Weekly seminars hosted by the CVI
Fall 2020
All CVI Seminars for Fall 2020 will be held at 4:00 PM virtually via BlueJeans. Click the link below to enter the event:
https://primetime.bluejeans.com/a2m/live-event/zpdrxfdw
September 2020
Kiran Musunuru, M.D., Ph.D., M.P.H., M.L.
Perelman School of Medicine
September 16, 2020
Vinicio de Jesus Perez, M.D.
Stanford University Medical Center
September 23, 2020
Joshua Wythe, Ph.D.
Baylor College of Medicine
September 30, 2020
October 2020
Leslie Leinwand, Ph.D.
Colorado University Denver School of Medicine
October 7, 2020
Elizabeth Murphy, Ph.D.
NHLBI
October 14, 2020
William Pu, M.D.
Harvard Medical school & Boston Children's Hospital
October 28, 2020
November 2020
Martin Young, Ph.D.
The University of Alabama at Birmingham
November 4, 2020
Jennifer Davis, Ph.D.
University of Washington
November 11, 2020
Arndt Siekmann, Ph.D.
Perelman School of Medicine
November 18, 2020
December 2020
Marcus Goncalves, M.D., Ph.D.
Cornell University
December 2, 2020
Sharlene Day, M.D.
Perelman School of Medicine
December 9, 2020
Benoit Bruneau, Ph.D.
Gladstone Institute of Cardiovascular Disease
December 16, 2020
Close
Past Seminars
A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z
A
Zoltan Arany, M.D., Ph.D.
Perelman School of Medicine
New Players in Mitophagy
December 12, 2018
Euan Ashley, M.D.
Stanford University
1 to 100,000 Single Cells to Populations in Cardiovascular Genomics
February 28, 2018
B
Robert Balaban, Ph.D.
National Heart, Lung, and Blood Institute
The Mitochondria Reticulum of Muscle Cells
December 11, 2019
Gerd Blobel, M.D., Ph.D.
Perelman School of Medicine
Genome and Epigenome Editing to Treat Hemoglobinopathies
March 14, 2018
Laurie Boyer, Ph.D.
Massachusetts Institute of Technology
Programming and Reprogramming Cardiac Cell Fate
January 31, 2018
Paul Burridge, Ph.D.
Northwestern University
Pharmacogenomic Prediction and Prevention of Chemotherapy-Induced Cardiotoxicity using hiPSC
January 16, 2019
C
Thomas Cappola, M.D., Sc.M.
Perelman School of Medicine
Crossing the Translational Divide in Heart Failure
November 20, 2019
Kathleen Caron, Ph.D.
UNC-Chapel Hill
GPCR Regulation of Lymphatics in Health and Disease
February 13, 2019
Mete Civelek, Ph.D.
University of Virginia
Genetic Regulation of Vascular Smooth Muscle Cell Function
March 4, 2020
Kieran Clarke, Ph.D.
University of Oxford
A Ketone Drink for Heart Failure?
February 27, 2019
Kareen Coulombe, Ph.D.
Brown University
Re-Engineering Myocardium for Heart Regeneration
January 29, 2020
Peter Crawford, M.D., Ph.D.
University of Minnesota
Following Ketone Carbon Through Macrophages, Landing in Hepatic Fibrogenesis
January 30, 2019
D
E
Patrick Ellinor, M.D., Ph.D.
Massachusetts General Hospital
Atrial Fibrillation from Genetics to Mechanisms
March 6, 2019
John Elrod, Ph.D.
Lewis Katz School of Medicine at Temple University
Mitochondrial Calcium Signaling in Cardiac Physiology and Disease
February 7, 2018
F
Jason Fish, Ph.D.
University Toronto
Decoding the Non-coding Regulatory Pathways of Vascular Inflammation
October 3, 2018
Mark Fishman, M.D.
Massachusetts General Hospital
Genetic Architecture of Social Behavior in Zebrafish
May 9, 2018
Garret FitzGerald, M.D.
Perelman School of Medicine
Cardiovascular Hazard and NSAIDs
November 1, 2017
David Frank, M.D., Ph.D.
Children's Hospital of Philadelphia
Defining Mechanisms of Cardiopulmonary Cell Fate for Pediatric Pulmonary Hypertension Therapy
December 20, 2017
Sarah Franklin, Ph.D.
University of Utah School of Medicine
The Lysine Methyltransferase Smyd1 Regulates Growth and Metabolism in the Heart
September 25, 2019
G
Anna Gelzer D.V.M., Ph.D.
School of Veterinary School of Medicine
Spontaneous Models of Arrhythmogenic, Cardiomyopathic, and Valvular Disease
February 12, 2020
Guillermo Garcia-Cardena, Ph.D.
Brigham and Women’s Hospital, Boston
Novel Drivers of Endothelial Cell Dysfunction
April 10, 2019
Brian Glancy, Ph.D.
NHLBI
The Muscle Mitochondrial Reticulum
May 2, 2018
David Glass, M.D.
Regeneron Pharmaceuticals, Inc. & Harvard Medical School
Molecular Mechanisms of Aging, Including in Skeletal Muscle
January 15, 2020
Ira Goldberg, M.D.
New York University Langone Health
Feeding the Heart with Fat
October 30, 2019
Robert Gorman, M.D.
Perelman School of Medicine
Post-MI LV Remodeling: An Engineering Perspective with Implications for Regenerative Therapies
January 24, 2018
Daniel Greif, M.D.
Yale University School of Medicine
Vascular Mural Cells in Development and Disease
May 1, 2019
Courtney Griffin, Ph.D.
University of Oklahoma Health Sciences Center
Exploiting Chromatin-Remodeling Complexes to Study Vascular Development and Maintenance
May 15, 2019
Asa Gustafsson, Ph.D.
Skaggs School of Pharmacy and Pharmaceutical Sciences
Novel Mechanisms of Mitochondrial Quality Control in the Heart
December 19, 2018
H
Timothy Hla, Ph.D.
Boston Children's Hospital
Novel Insights into Endothelial GPCR Regulation of Transcriptional Mechanisms of Angiogenesis and Organotypic Specialization
February 5, 2020
Priscilla Hsue, M.D.
UCSF School of Medicine
HIV Infection, Inflammation and Cardiovascular Disease: 2018 Update
December 5, 2018
I
Erik Ingelsson M.D., Ph.D., F.A.H.A.
Stanford University
Ten Years and Hundreds of Novel Cardiovascular Loci: What Now?
May 16, 2018
J
Rajan Jain, M.D.
Perelman School of Medicine
Understanding How Genome Organization Regulates Cardiac Development and Disease
February 6, 2019
K
Mark Kahn, M.D.
Perelman School of Medicine
Valve Hemodynamics in Development and Disease
January 17, 2018
David Kass, M.D.
John Hopkins University School of Medicine
How PKG Regulates Protein Quality Control
December 4, 2019
Daniel Kelly, M.D.
Perelman School of Medicine
Fuel Metabolic Checkpoints as Targets for Cardiovascular Disease
October 4, 2017
Richard Kitsis, M.D.
Albert Einstein College of Medicine
Chemical and Structural Approaches to Manipulating Cell Death
November 7, 2018
Marc Kraus, D.V.M.
School of Veterinary School of Medicine
Spontaneous Models of Arrhythmogenic, Cardiomyopathic, and Valvular Disease
February 12, 2020
Calvin Kuo, M.D., Ph.D.
Stanford University School of Medicine
Molecular Regulation of the Blood-Brain Barrier
April 4, 2018
L
Kory Lavine, M.D., Ph.D.
Washington University School of Medicine in St. Louis
Leveraging Immune Cell Diversity in the Failing Heart
October 23, 2019
Mitchell Lazar, M.D., Ph.D.
Perelman School of Medicine
Transcriptional Regulation of Metabolism
November 29, 2017
Nicholas Leeper, M.D.
Stanford University School of Medicine
The Role of Efferocytosis in Cardiovascular Disease
September 19, 2018
Merry Lindsey, Ph.D.
University of Mississippi
Cardiac Remodeling After Myocardial Infarction
October 2, 2019
M
Andy Marks, M.D.
Columbia University
What Makes the Heart Pump: High Resolution Structure and Function of the Ryanodine Receptor
October 18, 2017
James Martin, M.D., Ph.D.
Baylor College of Medicine
Hippo Signaling in Heart Regeneration
January 10, 2018
Megan McCain, Ph.D.
University of Southern California
Engineering "Heart on a Chip" Platforms for Cardiac Disease Modeling
March 13, 2019
Tim McKinsey, Ph.D.
University of Colorado Denver - Anschutz Medical Campus
Protein Acetylation in Heart Failure: The Epigenome and Beyond
April 11, 2018
Jeffery Molkentin, Ph.D.
Cincinnati Children’s Hospital Medical Center
An Acute Immune Response Underlies the Benefit of Cardiac Adult Stem Cell Therapy
April 3, 2019
Edward Morrisey, Ph.D.
Perelman School of Medicine
Ensuring the Cardiovascular System Has Something to Work With: Building and Rebuilding the Lungs
March 20, 2019
Deborah Muoio, Ph.D.
Duke University Medical Center
Integrating Molecular Phenomics and Respiratory Fluxomics to Decipher the Metabolic Basis of Heart Failure
October 24, 2018
Kiran Musunuru, M.D., Ph.D.
Perelman School of Medicine
Discovery and Therapeutic Genome Editing of Coronary Heart Disease Genes
December 6, 2017
N
Matthias Nahrendorf, M.D., Ph.D.
Massachusetts General Hospital
Innate Immunity and Cardiovascular Health
October 16, 2019
Stefania Nicoli, Ph.D.
Yale School of Medicine
RNA Mechanisms Governing Endothelial Cell Behaviors in Development and Homeostasis
January 22, 2020
O
Mark Oyama, D.V.M., M.S.C.E.
School of Veterinary School of Medicine
Spontaneous Models of Arrhythmogenic, Cardiomyopathic, and Valvular Disease
February 12, 2020
P
Kit Parker, Ph.D.
Harvard University
Designing, Building, and Testing Muscular Pumps
February 20, 2019
Liming Pei, Ph.D.
Perelman School of Medicine
Listen to your Heart
December 13, 2017
Jorge Plutzky, M.D.
Harvard Medical School
Joint IDOM/CVI Seminar
May 22, 2019
Michael Potente, M.D.
Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany
Metabolic Regulation of Endothelial Growth State
October 9, 2019
Benjamin Prosser, Ph.D.
Perelman School of Medicine
Cardiomyocyte Mechanobiology in Health and Heart Failure
September 26, 2018
Q
R
Daniel Rader, M.D.
Perelman School of Medicine
New Biology in Cardiometabolic Traits Revealed Through Human Genetics
November 8, 2017
Kristy Red-Horse, Ph.D.
Stanford University
Building and Rebuilding the Heart: Coronary Artery Development and Regeneration
January 23, 2019
Howard Rockman, M.D.
Duke University School of Medicine
Biased G Protein-Coupled Receptor Signaling
March 27, 2019
S
Michael Sacks, Ph.D.
The University of Texas at Austin
Multi-Resolution Models of the Mitral Heart Valve: From Mechanobiology to Surgical Repair
October 31, 2018
Vijay Sankaran, M.D., Ph.D.
Broad Institute of MIT and Harvard
Genetic Studies of Human Hematopoiesis
November 28, 2018
Sydney Shaffer, M.D., Ph.D.
Perelman School of Medicine
Making Sense of Transcriptional Heterogeneity in Rare Cells
February 19, 2020
Shey-Shing Sheu, Ph.D., F.A.H.A.
Thomas Jefferson University
Defeating Heart Failure with Energy: Mechanisms of Cardiac Excitation-Contraction-Energetics Coupling
October 10, 2018
Raymond Soccio, M.D., Ph.D.
Perelman School of Medicine
Genetics of Gene Regulation by PPAR Nuclear Receptors in Cardiometabolic Disease
May 23, 2018
Didier Stainier, Ph.D.
Max Planck Institute for Heart and Lung Research
Biological Robustness: Genetic Compensation and Transcriptional Adaptation
February 26, 2020
Matthew Steinhauser, M.D.
Brigham and Women’s Hospital, Division of Cardiovascular Medicine
White Adipose Plasticity and Systemic Insulin Resistance
November 13, 2019
Katalin Susztak, M.D., Ph.D.
Perelman School of Medicine
APOL1: The Balance Imposed by Infection, Selection, Kidney and Cardiovascular Disease
May 8, 2019
T
Ira Tabas, M.D., Ph.D.
Columbia University Irving Medical Center
Macrophage Metabolism in Atherosclerosis
September 3, 2019
Alan Tall, M.D.
Columbia University
Lipids, Hematopoiesis and Athero-Thrombosis
February 14, 2018
Rong Tian, M.D., Ph.D.
University of Washington
Is Metabolism a Driver in Pathological Remodeling of the Heart?
March 7, 2018
U
V
Benjamin Voight, Ph.D.
Perelman School of Medicine
One Shot, One Opportunity: Making it Count with Computational Human Genomics
October 25, 2017
Tom Vondriska, Ph.D.
UCLA
Epigenomics of Cardiovascular Disease
April 24, 2019
W
Douglas Wallace, Ph.D.
Hospital of the University of Pennsylvania
A Mitochondrial Etiology of Complex Diseases
October 11, 2017
Kenneth Walsh, Ph.D.
Boston University School of Medicine
Somatic Mutations, Clonal Hematopoiesis and Cardio-metabolic Risk
Jamuary 3, 2018
Yibin Wang, Ph.D.
UCLA David Geffen School of Medicine
Common Pathway in Cardiometabolic Regulation: Signaling Beyond Bioenergetics
April 25, 2018
Hao Wu, Ph.D.
Perelman School of Medicine
Decoding Human Ventricular Cardiomyocyte Specification and Maturation with Integrated Cell-Type Specific Epigenomic and Transcriptomic Analysis
October 17, 2018
X
Y
Z
Close
TRIPS Series (Trainee Research in Progress Seminar Series)
All Trips Seminars are held virtually via the link below:
https://bluejeans.com/741347201
September 8, 2020 @12pm
Aileen Ren, BA
Kahn Laboratory
Downstream Mechanisms of Vascular Malformation
Joseph Park, BA
Rader Laboratory
Exome Wide Evaluation of Rare Coding Variants Using Electronic Health Record Data to Identify Novel Gene Phenotype Associations
October 20, 2020 @12pm
Emily Scarborough, PhD
Prosser Laboratory
Microtubules Enable Cardiac Growth Via Localization of mRNA and Translational Machinery
Katherine Quiroz-Figueroa BS
Rader Laboratory
Hepatic TRIB1 Regulates LDL Metabolism Through CEBPα - Mediated Regulation of the LDL Receptor
November 10, 2020 @12pm
Ingrid Marti-Pamies, PhD
Scherrer-Crosbie Laboratory
Brown Adipose Tissue and Cardioprotection : Targeting BMP3b on Myocardial Ischemia Reperfusion
Natasha Jaiswal, PhD
Titchenell Laboratory
Akt Regulates Muscle Growth and Function via Coordinated Regulation of mTORC1 and FoxO1
December 8, 2020 @12pm
Thomas Keller, PhD
Kahn Laboratory
Lymphangiogenesis is not Required for Recovery from Myocardial Infarction
Ling Lai, MD, PhD
Kelly Laboratory
Delineating the Upstream Regulators of PGC 1a in Melanoma Using Functional Genomic Screens
Close
Workshops
Note: All workshops are RSVP REGISTRATION ONLY as seats are limited. Contact Emily Schuster (emily.schuster@pennmedicine.upenn.edu) for more information.
Tuesday, November 27, 2018 12pm, Smilow 11-146AB
CRISPR-Cas9 Genome Editing Bootcamp (Advanced Level)
Dr. Kiran Musunuru
Genome-editing tools, particularly CRISPR-Cas9, are transforming biomedical investigation. This practical, hands-on workshop, organized by the CVI Genetic and Epigenetic Origins of Disease (GEODe) Program, is intended for anybody interested in learning how to use CRISPR-Cas9-based technologies. The advanced-level workshop will follow a flipped-classroom, active-learning model. Participants will review an online video/slides before the meeting. In the workshop, participants will work in teams on virtual experiments in which base editing, epigenome editing, and other advanced concepts are explored (requiring participants to bring their own WiFi-capable laptops).
Tuesday, September 18, 2018 12pm, Smilow 11-146AB
CRISPR-Cas9 Genome Editing Bootcamp (Basic Level)
Dr. Kiran Musunuru
Genome-editing tools, particularly CRISPR-Cas9, are transforming biomedical investigation. This practical, hands-on workshop, organized by the CVI Genetic and Epigenetic Origins of Disease (GEODe) Program, is intended for anybody interested in learning how to use CRISPR-Cas9-based technologies. The basic-level workshop will follow a flipped-classroom, active-learning model. Participants will review an online video/slides before the meeting. In the workshop, participants will work in teams on virtual experiments in which knockout/knock-in mice and cell lines are generated (requiring participants to bring their own WiFi-capable laptops). Participants will learn online tools to design CRISPR-Cas9 reagents, common pitfalls to avoid, and interpreting data from genome-editing experiments.
Monday, May 14, 2018 12pm, Smilow 11-146AB
CRISPR-Cas9 Genome Editing Bootcamp (Advanced Level)
Dr. Kiran Musunuru
Genome-editing tools, particularly CRISPR-Cas9, are transforming biomedical investigation. This practical, hands-on workshop, organized by the CVI Genetic and Epigenetic Origins of Disease (GEODe) Program, is intended for anybody interested in learning how to use CRISPR-Cas9-based technologies. The advanced-level workshop will follow a flipped-classroom, active-learning model. Participants will review an online video/slides before the meeting. In the workshop, participants will work in teams on virtual experiments in which base editing, epigenome editing, and other advanced concepts are explored (requiring participants to bring their own WiFi-capable laptops).
Tuesday, January 23, 2018 12pm, Smilow 11-146AB
CRISPR-Cas9 Genome Editing Bootcamp (Basic Level)
Dr. Kiran Musunuru
Genome-editing tools, particularly CRISPR-Cas9, are transforming biomedical investigation. This practical, hands-on workshop, organized by the CVI Genetic and Epigenetic Origins of Disease (GEODe) Program, is intended for anybody interested in learning how to use CRISPR-Cas9-based technologies. The basic-level workshop will follow a flipped-classroom, active-learning model. Participants will review an online video/slides before the meeting. In the workshop, participants will work in teams on virtual experiments in which knockout/knock-in mice and cell lines are generated (requiring participants to bring their own WiFi-capable laptops). Participants will learn online tools to design CRISPR-Cas9 reagents, common pitfalls to avoid, and interpreting data from genome-editing experiments.
Close
CV Grand Rounds